Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT06947694
Eligibility Criteria:
Inclusion Criteria:
* Patient must meet all of the following inclusion criteria to be enrolled in this study:
1. Non-small cell lung cancer diagnosed initially through pathological histology.
2. There are 3-6 metastatic lesions.
3. No brain metastasis or the lesions are stable.
4. Negative for driver genes (including EGFR, ALK, ROS, BRAF, MET, RET genes. Note: The above English terms are all gene names).
5. ECOG (Eastern Cooperative Oncology Group) score: 0-1 point, with an expected, survival period of more than 3 months.
6. Aged between 18 and 75 years old.
7. Evaluated by PET-CT (including FDG and FMISO, not mandatory).
8. No contraindications for immunotherapy and radiotherapy.
9. The informed consent form has been signed.
Exclusion Criteria:
* Patients with any of the following criteria are not eligible for enrollment in this study:
1. Those with severe dysfunction of vital organs (heart, liver, kidney).
2. Those accompanied by other malignant tumors.
3. Those with uncontrolled heart diseases or having experienced a myocardial infarction within the past six months.
4. Those with a history of mental illness.
5. And other situations in which the researchers deem it inappropriate for the subjects to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06947694
Study Brief:
Protocol Section:
NCT06947694